Seeking high level development as an important topic in the API industry

Guide reading: the development of China's raw material medicine industry is early, a considerable number of raw materials and drug enterprises have entered the international track, many raw materials and drug production enterprises have been certified by the international market, and the international market share of China's raw materials has been gradually improved. Therefore, the background of API production is quite gratifying, but API enterprises should continue to think about how to seize opportunities and seek for a higher level of development.

Seeking high level development as an important topic in the API industry

As an important part of the field of medicine, the development trend of the pharmaceutical industry is good in recent years. However, "there is no foresight and worry". The export of raw materials in China is in fact in the opportunity and challenge, and the related enterprises need to realize the many factors that the current industry faces.

First, the global economic recovery is slow, the growth of the European and American pharmaceutical market is limited. There is a certain uncertainty in the growth of the emerging pharmaceutical market. The continued growth of the demand for the international pharmaceutical market is not optimistic. The risk of the export of raw materials in China is increasing. Secondly, the main competition in India is serious for the depreciation of the hand currency, and the RMB is still there. The international market competitive advantage of China's APIs has been further weakened. Third, the domestic environmental standards, raw materials and labor costs still have a growing trend, which will continue to increase the cost of China's raw material products; fourth, the low price competition caused by the excess capacity of bulk raw materials will lead to China The export of API products is in a dilemma. Fifth, frequent trade frictions and the rise of foreign trade protectionism will also pose a severe challenge to China's exports.

As the largest producer and exporter of API in the world, the domestic API industry has laid a solid foundation for the development of the industry, providing good material conditions for the industry's transformation and upgrading. In addition, the support of the prosperous pharmaceutical market and policy will promote the development of the industry.

In addition, under the background of national sustainable development strategy, API production should conform to the trend of the times and actively seek its own way of sustainable development. Enterprise transformation is not only the requirement of the national policy, but also a new direction for the development of the enterprise itself. It is more reasonable and feasible to develop the energy saving and environmental protection production mode.

In a word, it is not possible to solve the problem of API at one stroke. It requires many efforts and efforts. As long as the parties have common understanding and joint efforts, it is hopeful to solve these problems. On the basis of improving the quality of the products, the enterprises should consolidate the technical strength and concentrate their energies on the road of innovation and make the enterprises on the road of sustainable development.